ANXA5 and familial pancreatic carcinoma: Annexin V and TUNEL assays demonstrated that ectopic expression of miR-181c reduced the apoptosis rate of PANC-1 and BxPC3 pancreatic cancer cells by resisting to the chemotherapeutic agent gemcitabine (Figure 4A and 4B).